Industry Events

The American Society of Breast Surgeons (ASBrS) is pleased to offer Industry Events to the breast surgery community. Webinars are educational programs sponsored and funded by an outside organization, independently organized, and offered, and have been made possible through marketing support and advertising fees. Content is updated as programming details are received. See below for Upcoming Events and on-demand events: 20222021 & 2020.

Interested in Supporting an Activity or Webinar?

Please contact Marti Boyer at mboyer@breastsurgeons.org.


The following industry activities are supported by specific companies through marketing grants and advertising fees. They are not part of the official education program of the ASBrS, and most events are free to all members. By clicking the links posted below, please understand you may leave the ASBrS website and go to a website not operated by the Society.


October 7–8, 2022

Location: Weehawken, NJ


Mammotome

Breast Fellows Complimentary Education

Overview:

Dr. Kandace McGuire and Dr. David Kaufman lead this complimentary hands-on course where you will develop proficiency in these and other techniques to advance your skills in the OR:

  • Wire-free lesion and radiation-free lymphatic localization
  • Delayed SLNB
  • Intraoperative ultrasound
  • Ultrasound-guided vacuum-assisted breast biopsy
  • Working with hospital administration and industry

Attendees will experience a variety of technologies through didactic lectures and hands-on skills labs.

Registration:

For More Information:

Please contact Nikki Irwin at nikki.irwin@mammotome.com.


Note: This activity is supported by Mammotome through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to Breast Fellows.

October 13–15, 2022


Australasian International Breast Congress (AIBC)

Overview:

On October 13-15, 2022, the Australasian Society for Breast Disease (ASBD), World Congress on Controversies in Breast Cancer (CoBrCa) and Breast Surgeons of Australia and New Zealand (BreastSurgANZ), will hold an international congress focusing on controversial issues in breast diseases including presentations, debates and discussions. For more information, visit aib-congress.org.

Learn More:

 2022 Events on Demand

Endomag

ImpediMed

Mammotome

Merit Medical

Natera

PeerView Institute

Perimeter Medical Imaging, AI

Physicians’ Education Resource®, LLC (PER®)

PreludeDx


Endomag

23rd Annual Meeting Symposium
Controversy in breast and axilla surgical guidance: Not all seeds and tracers are created equal


Moderator:

  • Susan Boolbol, MD

Panelists:

  • Brigid Killelea, MD, FACS
  • Michael Alvarado, MD
  • Anne Peled, MD
  • Lucy De La Cruz, MD

Description:

Not all seeds and tracers are created equal… join us as we take a deep-dive in to the technologies currently available for seed localization and axillary staging, alongside a world-class panel of breast surgical oncologists, with years of collective experience across all available seed localization devices on the market. The great localization debates will tackle everything from seed reliability to MRI visibility, metal instruments, accuracy of measurement, clinical efficacy, and much more.

That’s followed by the world-first, in-person launch of the next generation Sentimag® system and new Magseed® markers - built by Endomag, designed by you. Taking on board feedback from thousands of physicians worldwide, see how the new system has built on the strengths that have made Sentimag® so widely adopted, plus added an abundance of new advanced features.


Note: Symposia at the Society's 23rd Annual Meeting were educational programs sponsored and funded by an outside organization, independently organized, and offered. This symposium was supported by Endomag through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 4/06/2022

ImpediMed

PREVENT Meets Primary Endpoint:
A Detailed Look at the Practice-Changing Results and Real-World Experience with Breast Cancer-Related Lymphedema Prevention Cancer Care


Description:

PREVENT, the largest randomized clinical trial to assess lymphedema prevention, met its primary endpoint. Join our panel of experts as they debate the recently published results and implications for the future of breast cancer care. Topics covered will include the importance of early lymphedema detection and intervention, supporting clinical evidence, and real-world experience with clinical implementation. Discover how providing your patients with a lymphedema prevention program provides optimal patient care and can positively impact your practice.

Moderated By:

  • Dr. Pat Whitworth
    Director
    Nashville Breast Center

Faculty:

  • Dr. Beth DuPree
    Breast Surgeon
  • Dr. Manpreet Kohli
    Breast Surgeon
    Breast Program Director Monmouth Medical Center
  • Dr. Chirag Shah
    Co-Director Comprehensive Breast Program
    Director of Breast Cancer Radiation Oncology and Director of Clinical Research, Department of Radiation Oncology, Cleveland Clinic

Educational Objectives:

  • Understand the latest evidence from the PREVENT trial
  • Discover the benefits of identifying and treating lymphedema at the subclinical stage
  • Learn the best practices and economics for implementing a lymphedema prevention program

Note: This webinar is supported by ImpediMed through a marketing grant. It is not part of the official ASBrS online program and no AMA PRA Category 1 Credits™ have been assigned to them by the ASBrS.
Originally Aired: 3/22/2022

Mammotome

23rd Annual Meeting Symposium
De-Escalation of Axilla Surgery with Magnetic Markers


Program Objective:

Go beyond wire-free localization into the advanced procedures of TAD and Delayed SLNB. Top experts from around the world review the latest data, the emerging procedures, and share their OR footage of their experiences. Get a glimpse of what’s on the horizon with the next generation Sentimag and dive into the ongoing research.

Agenda:

  • The Latest Magseed® TAD Data
    Mr. Peter Barry, London’s Royal Marsden
  • Delayed SLNB: The Future of Axillary Staging
    Kandace P. McGuire, MD - VCU
    Melissa Fana, MD - Northwell Health
  • Magtrace Efficacy for SLNB Post-NAC
    Dr. Stefan Paepke, MD - Technical University of Munich
  • SentiNOT 2.0 Trial and Recruitment Process
    Betsy Bonefas, MD – Baylor College of Medicine

Note: Symposia at the Society's 23rd Annual Meeting were educational programs sponsored and funded by an outside organization, independently organized, and offered. This symposium was supported by Mammotome through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 4/08/2022

Merit Medical

23rd Annual Meeting Symposium
Disruptive Innovation: Harness the Power of RADAR


Description:

SCOUT® Radar localization exclusively spans the care continuum from time of biopsy placement to Targeted Axillary Dissection to excellent surgical outcomes. Discover the state-of-the art localization and lymphatic mapping techniques practiced by key opinion leaders from the Cleveland Clinic and University of Colorado. Learn about upcoming SCOUT product enhancements and the clinical and economic rationale for placing SCOUT at Time of Biopsy.

Panelists:

  • Brian Czerniecki, MD, PhD
  • Colleen Murphy, MD, FACS
  • Anne Peled, MD
  • Stephanie Valente, DO, FACS

Note: Symposia at the Society's 23rd Annual Meeting were educational programs sponsored and funded by an outside organization, independently organized, and offered. This symposium was supported by Merit Medical through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 4/08/2022

Natera

Better Together: ctDNA and Germline Testing


Description:

In this 30 minute clinical presentation, hear from Dr. Angel Rodriguez on how germline and somatic testing together can inform your surgical decisions, and identify more patients at high risk of cancer recurrence. This presentation will review the portfolio of Natera oncology solutions for germline and somatic testing including Signatera molecular residual disease (MRD) testing and Empower hereditary cancer testing (HCT).

For More Information:

Contact Wing-Kit Chu, Associate Director, Hereditary Cancer Marketing, at wichu@natera.com.


Note: This webinar is supported by Natera through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 8/03/2022

PeerView Institute

23rd Annual Meeting Symposium
Expanding the Benefits of PARP Inhibitor Therapy to More Patients With Breast Cancer and Earlier Disease Settings: Multidisciplinary Perspectives on How to Maximize the Potential of PARP Inhibitors and Optimize Their Use as Part of Multimodal Management of Breast Cancer


Program Objectives:

Upon completion of this CE activity, participants will be able to:

  1. Describe DNA damage response (DDR) pathways and the rationale for therapeutic targeting of DDR with PARP inhibitors in early and advanced breast cancer
  2. Identify patients with breast cancer who might benefit from treatment with PARP inhibitors based on current evidence and best practices for biomarker testing
  3. Integrate PARP inhibitors into evidence-based, individualized treatment plans for eligible patients with early and advanced breast cancer considering latest efficacy and safety data in the context of clinical practice or clinical trials
  4. Manage treatment-related adverse events in patients receiving PARP inhibitors for breast cancer treatment

Description:

Poly (ADP-ribose) polymerase (PARP) inhibition is now the standard of care for metastatic breast cancer harboring a germline BRCA1 or BRCA2 mutation, and studies continue to investigate PARP inhibitors as monotherapies or in rational combinations. Most recently, exciting results have revealed a potential role for PARP inhibitor therapy in earlier disease settings where there is a possibility for cure, heralding a new era of targeted therapy for patients with breast cancer. In order to maximize the benefits of these advances, it is crucial for the multidisciplinary breast cancer care team to keep current with the latest data and expert recommendations to effectively integrate PARP inhibitor therapy into clinical practice, as well as genetic counseling and biomarker testing to refine individualized therapy selection.

This PeerView Live Clinical Consults event for in-person and virtual attendees will provide essential information on the biologic rationale for targeting PARP, the latest data and their practical implications, guidance for optimizing biomarker testing, and strategies for improving multidisciplinary collaboration so that patients with breast cancer can make the most of the recent advances with PARP inhibitor therapy.

Accreditation, Support, and Credit:

In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity is supported by independent educational grants from AstraZeneca and Merck & Co., Inc.


Note: This satellite symposium is supported by AstraZeneca and Merck & Co., Inc. through independent educational grants. This activity is provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. CME credits for this activity will be provided by Medical Learning Institute, Inc. It is not part of the official program of the ASBrS*. This activity is free to all registered attendees. (*An independent symposium fee from Medical Learning Institute, Inc. was provided to the ASBrS in order to offer this satellite symposium during the 23rd Annual Meeting.)
Originally Aired: 4/08/2022

Perimeter Medical Imaging, AI

23rd Annual Meeting Symposium
OCT + Future AI: Changing the Paradigm for Intraoperative Margin Visualization


Featured Guests:

  • Moderator: Dr. Richard Fine, Margaret West Comprehensive Breast Center, Memphis, TN
  • Dr. Amelia Tower, Texas Health Breast Specialists, Fort Worth, TX
  • Dr. Maryam Elmi, The START Center for Cancer Care, San Antonio, TX

Join us for an educational session on the intraoperative use of Perimeter’s groundbreaking margin visualization technology powered by Optical Coherence Tomography (OCT), bringing clarity to margin status at the point of care.

This presentation will cover:

  • Technology behind Perimeter’s S-Series OCT, delivering high-resolution specimen imaging for intraoperative margin visualization
  • OCT correlations with pathology
  • Workflow for bringing OCT into your OR
  • Lumpectomy case reviews, including recognizing suspicious tissues
  • Bringing AI* to the operating room and investigational study updates
  • Panel discussion and Q&A

*Perimeter is currently conducting a randomized control trial to assess its B-Series OCT imaging platform combined with AI technology on the impact of positive margin rates during breast conservation surgery. Perimeter B-Series OCT with ImgAssist AI is not available for sale in the United States. CAUTION: Investigational Device. Limited by U.S. law to investigational use.

Perimeter’s S-Series OCT is cleared by the FDA and available for sale in the U.S.


Note: Symposia at the Society's 23rd Annual Meeting were educational programs sponsored and funded by an outside organization, independently organized, and offered. This symposium was supported by Perimeter Medical Imaging, AI, through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 4/08/2022

Physicians’ Education Resource®, LLC (PER®)

23rd Annual Meeting Symposium
Navigating Adjuvant Decision-Making for High-Risk Early-Stage Hormone Receptor-Positive Breast Cancer: An Expert Tumor Board Discussion


Overview:

During this live satellite symposium, a multidisciplinary panel of experts in the management of early-stage HR+/HER2- breast cancer will engage in a case-based discussion regarding the personalization of adjuvant therapy for these patients, particularly those with high-risk disease. Topics will include clinical and molecular factors for risk assessment, recent clinical data with endocrine regimens integrating CDK4/6 inhibitors, and management of adverse events associated with new agents. This program will highlight current best practices and the integration of emerging data into daily practice to optimize outcomes for patients with early-stage HR+/HER2- breast cancer, using a lively tumor-board format with opportunity for audience questions and interaction.

For help or questions please contact: info@gotoper.com.


Note: Symposia at the Society's 23rd Annual Meeting were educational programs sponsored and funded by an outside organization, independently organized, and offered. This symposium was supported by Physicians’ Education Resource®, LLC (PER®) through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 4/09/2022

PreludeDx

Newly Published Data Review of DCISionRT Randomized SweDCIS Results and the Clinical Utility for Oncoplastic Surgical Planning


Description:

Join us for a published data review of the highly anticipated DCISionRT validation results in the randomized SweDCIS patient cohort. Practicing physicians will be discussing implications of this new data and the clinical utility of DCISionRT in minimizing over- and under-treatment of DCIS patients. There will be interactive discussions about meaningful application of DCISionRT into surgical practice and real-world patient case studies regarding oncoplastic surgical planning.

Faculty:

  • Anne Peled, MD
    Co-Director, Sutter CPMC Breast Cancer Program
  • Karen Barbosa, DO, FACOS
    Breast Surgeon and Oncoplastic Surgeon and Medical Director, TidalHealth Delaware Breast Cancer Program
  • Pat Whitworth, MD, FACS
    Breast Surgical Oncology Specialist, Director of the Nashville Breast Center
  • Chirag Shah, MD
    Co-Director of the Comprehensive Breast Program, Cleveland Clinic
  • Troy Bremer, PhD
    Founder and CSO of PreludeDx

For More Information:

Contact alindsay@preludedx.com, cdunn@preludedx.com


Note: This webinar is supported by PreludeDx through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 3/15/2022

 2021 Events on Demand

3M+KCI

Agendia

Ambry Genetics

Bayer

Cardinal Health

Endomag

Exact Sciences

Hologic

Medtronic

Mammotome

Merit Medical

Pacira BioSciences, Inc.

Perimeter Medical Imaging AI, Inc.


3M+KCI

22nd Annual Meeting Symposium
Minimizing Post-operative Complications Following Major Breast Surgery


Description:

Please join us for a case-based discussion on innovative solutions that may minimize complications after challenging breast surgery cases. Contact Alexandra Castillo at acastillo8@mmm.com.


Note: Symposia at the Society's 22nd Annual Meeting were educational programs sponsored and funded by an outside organization, independently organized, and offered. This symposium was supported by 3M+KCI through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 4/30/2021

Agendia

22nd Annual Meeting Symposium
A Case-Based Discussion of Integrating MammaPrint and BluePrint into Treatment Planning for Patients with Early Stage Breast Cancer


Description:

This symposium will feature a case-based discussion of Mammaprint and Blueprint's clinical utility for patients with Early-Stage Breast Cancer. Pat Whitworth, MD, and William Audeh, MD, will discuss real world evidence and published clinical data in the context of patient care. Attendees will participate in an interactive Q&A at the end of the presentation.


Note: Symposia at the Society's 22nd Annual Meeting were educational programs sponsored and funded by an outside organization, independently organized, and offered. This symposium was supported by Agendia through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 4/30/2021

Agendia

A New Paradigm in Treatment Planning: Integrating Molecular Subtyping as Part of Comprehensive Genomic Profiling into Routine Clinical Care for Patients with Breast Cancer


Presenter:

  • William Audeh, MD
    Chief Medical Officer, Agendia

Discussant:

  • James Pellicane, MD
    Director of Breast Oncology, Bon Secours Cancer Institute

For More Information:

Contact Israel Madera at israel.madera@agendia.com.


Note: This webinar is supported by Agendia through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 2/16/2021

Agendia

Genomic Profiling of Early Stage Breast Cancer: Expanding Applications to Improve Outcomes


Description

This webinar will empower you with data demonstrating the utility of Agendia’s assays, MammaPrint® and BluePrint®, for patients with breast cancer. Review the latest data and learn about the real-world impact of MammaPrint and BluePrint. Please join us for an informative, interactive webinar.

Originally Aired: 12/14/2021

Ambry Genetics

Expanding Surgical Patient Reach: Earlier Detection through Integration of an End-to-End Solution


Description:

Join us as we discuss how to strengthen the patient and provider journey toward an individualized treatment plan. The CARE Program™ provides an end-to-end solution that can help identify high-risk patients earlier for potential proactive medical management and preventative procedures.

Brochure:

Access PDF

Speakers:

  • Anjali Date, MD
    Sheila R. Veloz Breast Center Lead Interpreting Physician
  • Mari Shay, BSN, RN
    Sheila R. Veloz Breast Center Manager, Women’s Imaging Services
  • Kory Jasperson, MS, CGC
    Director, Clinical Services, Ambry Genetics

Note: This webinar is supported by Ambry Genetics through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 3/16/2021

Bayer

Risk Stratified Breast Screening


Description:

Dr. Gillian Newstead (MD, FACR), Director of Global Breast Imaging at University of Chicago, will be talking about Risk Stratified Breast Screening and discussing the importance of breast density. She will share recommendations from the American College of Radiology and the American Society of Breast Surgeons and highlight the importance of supplemental Breast MRI screening for women with specific high risk factors, including women with dense breast tissue.

For More Information:

Contact Lainey Kasian at lainey.kasian@bayer.com.


Note: This webinar is supported by Bayer through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 8/24/2021

Cardinal Health

How to Navigate the Impact of COVID-19 on Your Breast Cancer Practice


Description:

In honor of Breast Cancer Awareness Month, we invite you to join a complimentary webinar led by Linda Han, MD, FACS, PPG, Director of Breast Oncology at the Parkview Cancer Institute, where she will discuss the impact of COVID-19 on breast cancer care. During this hour-long webinar we’ll walk through:

  • How to screen safely
  • Best practices for following guidelines
  • The impact on cancer-related mortality
  • And provide a forum for Dr. Han to answer your questions

About the Speaker:

  • Linda Han, MD, FACS, PPG
    Director of Breast Oncology
    Parkview Cancer Institute

Dr. Han currently serves as the Director of Breast Oncology at Parkview Cancer Institute and Chief Surgery Quality and Optimization Officer for Parkview Health in Fort Wayne, Indiana. She continues to remain active in surgical education as an adjunct professor of clinical surgery and has received numerous teaching awards for excellence in resident and medical student education.


Note: This webinar is supported by Cardinal Health through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 10/19/2021

Endomag

22nd Annual Meeting Symposium
Tissue Localization – The Future is Paramagnetic


Description:

Presenting the latest data on seed localization, featuring results from iBRA-NET, the world’s largest multicenter seed localization study with over 1,000 patients and the latest findings for TAD with Magseed® from the University of Texas MD Anderson Cancer Center. This is followed by a roundtable Q&A and an exclusive sneak peek at the new Sentimag® Gen 3 platform. For more information, contact Mathew Stephens (mstephens@endomag.com) or Connor Jipps (cjipps@endomag.com).


Note: Symposia at the Society's 22nd Annual Meeting were educational programs sponsored and funded by an outside organization, independently organized, and offered. This symposium was supported by Endomag through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 5/1/2021

Exact Sciences

22nd Annual Meeting Symposium
De-escalating Breast Cancer Surgery with Neoadjuvant Endocrine Therapy


Description:

Dr. Christy Russell, Sr. Director of Global Medical Affairs at Exact Sciences, and Dr. Susan Boolbol, System Chief of the Breast Surgical Oncology and Breast Program at Nuvance Health, discuss the utility of neoadjuvant endocrine therapy to de-escalate breast and axillary surgery in HR-positive, HER2-negative breast cancer patients. The presentation will also review data pertaining to biomarkers used to make neoadjuvant treatment decisions, including the Oncotype DX Breast Recurrence Score® test. For more information, contact Thomas Mallick (tmallick@exactsciences.com).


Note: Symposia at the Society's 22nd Annual Meeting were educational programs sponsored and funded by an outside organization, independently organized, and offered. This symposium was supported by Exact Sciences through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 4/29/2021

Hologic

The Reconstructive Lumpectomy™: Beyond the Fundamentals–Techniques for the Breast Surgeon


Description:

A Live Hologic Virtual Course featuring Cadaveric Assessment and Surgical Skills Advancement. Each of the three recorded sessions include lecture and case examples presented by renowned faculty, cadaveric demonstration of skills, introduction to technology, interactive panel discussion, and the opportunity to ask questions of the panel.

Brochure:

Access PDF

Topics Include:

  • Applied Breast Anatomy
  • Aesthetic Scar Placement
  • Donut Mammoplasty and Modifications for all quadrants
  • Managing Complications in Oncoplastic Breast Surgery
  • Multi-Disciplinary Decision Making

Educational Objectives:

After completing this course, the surgeon will be able to:
  • Perform aesthetically state of the art surgeries with optimal outcomes
  • Understand how technology can reduce re-excisions, returns to OR, and deliver state of the art treatment in an ever-changing health care climate
  • Treat tumors in all quadrants without a plastic surgeon
  • Have a strong fundamental understanding of breast anatomy and aesthetics to proceed with other training in Level II procedures
  • Identify and spot red flags that would lead to poor outcomes

Criteria for Participation:

Practicing breast or general surgeons who perform breast cases, practicing radiologists and radiation oncologists also welcome. Hologic reserves the right to accept or decline any registration or request for attendance. Attendees are limited to those practicing surgery, radiology, or radiation oncology.


Note: This webinar is supported by Hologic through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 3/10/2021, 3/20/2021, 3/31/2021

Hologic

22nd Annual Meeting Symposium
Updates and Education on the Principles and Practice of BioZorb® 3D Marker Utilization


Description:

Join the conversation with breast surgeons and a radiation oncologist as they discuss the role of a BioZorb® marker in a Reconstructive Lumpectomy™ surgery as well as the recent publication of the BioZorb® registry in the Annals of Surgical Oncology. Topics include communication with patients and practicing a multidisciplinary approach to patient care.

Faculty:

  • Dr. Cary Kaufman
  • Dr. Kiran Devisetty
  • Dr. Ashley Richardson
  • Dr. Lorraine Tafra

Note: Symposia at the Society's 22nd Annual Meeting were educational programs sponsored and funded by an outside organization, independently organized, and offered. This symposium was supported by Hologic through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 5/1/2021

Mammotome

22nd Annual Meeting Symposium
Modernizing Axillary Management: Delayed SLNB for DCIS Patients


Description:

How can you spare up to 78% of high-risk DCIS patients axillary surgery? Join a panel of surgical experts as they discuss how they’re taking patient care to the next level with tailored axillary management procedures and sparing some patients SLNB.

  • Roundtable Discussion
  • Procedure Videos
  • Downloadable Resources

Note: Symposia at the Society's 22nd Annual Meeting were educational programs sponsored and funded by an outside organization, independently organized, and offered. This symposium was supported by Mammotome through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 4/30/2021

Medtronic

Insights from the Nipple Sparing Mastectomy Registry & Related Trending Topics


Description:

Join our Faculty for a one-hour webinar as they take a closer look at the ASBrS Nipple Sparing Registry data. Jay Harness, MD will moderate a panel discussion with Shawna Willey, MD, Beth DuPree, MD and William Scarlett, DO as they review how data insights can drive improvement of care and reduce complications in Nipple Sparing Mastectomies. We encourage audience participation, discussion and questions at the end. Please join us for an informative, interactive webinar.

Brochure:

Access PDF

Objectives:

  • Evaluate the Nipple Sparing Mastectomy Registry Data and discuss how the results can be used to influence patient outcomes.
  • Review the science behind technologies that can help drive more efficient and effective care.
  • Discuss breast reconstruction options, including the considerations for patient selection.
  • Understand how to reduce complications using impact of technique, proper incision placements and tumescence in surgery.

Target Audience:

  • Breast Surgeons
  • General Surgeons
  • Plastic Surgeons
  • Healthcare Providers

Faculty:

  • Dr. Jay Harness
  • Dr. Shawna Willey
  • Dr. Beth DuPree
  • Dr. William Scarlett

Questions:

Contact Kirsten Gonya at kirsten.m.gonya@medtronic.com.


Note: This webinar is supported by Medtronic through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 3/2/2021

Medtronic

22nd Annual Meeting Symposium
Mitigating Risks & Complications in Nipple Sparing Mastectomies


Description:

Join our Faculty, Shawna Willey, MD, William Scarlett, DO, and Jay Harness, MD, for a one-hour virtual event as they take a closer look at Nipple Sparing Mastectomy risks & complications. They will discuss the importance of patient selection, the complication rates associated with various measurements, surgical approaches, and the benefits of the tools and technologies used in NSM. We encourage audience participation, discussion and questions at the end. For more information, contact Kirsten Gonya (kirsten.m.gonya@medtronic.com).


Note: Symposia at the Society's 22nd Annual Meeting were educational programs sponsored and funded by an outside organization, independently organized, and offered. This symposium was supported by Medtronic through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 4/30/2021

Merit Medical

Think Wire-Free w/ Dr. Madrigrano and Dr. Murphy. Advanced Utilization of SCOUT® Radar Localization for Breast Cancer Surgery


Presentation Highlights:

  • Utility for Oncoplastic Approaches
  • Targeted Axillary Dissection
  • Utility of Access Guide for Small Incisions
  • Case Reviews

Note: This webinar is supported by Merit Medical through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 6/16/2021

Merit Medical

Think Wire-Free w/ Dr. Barry Rosen and Dr. Mary Hayes. Post-COVID Strategies to Optimize Breast Cancer Care: A Patient-Centered Model


Description:

Join Advocate Health’s Barry Rosen, MD, and Memorial Healthcare’s Mary Hayes, MD, to learn how they uniquely employed SCOUT Radar Localization throughout the patient care continuum and throughout their systems to achieve streamlined, patient-centered care.

Brochure:

Access PDF

Presentation Highlights:

  • Cost and clinical advantages derived from going Wire-Free
  • Reducing patient facility visits through localizing with SCOUT at biopsy & data review
  • Clinical utility of SCOUT for Mastectomy and Oncoplastic approaches

Speakers:

  • Barry Rosen, MD, FACS
    Breast Team Leader, Advocate Healthcare, Chicago, IL
    Managing Partner, Targeted Medical Education (TME)
    Assistant Professor of Surgery Univeristy of Illinois College of Medicine
  • Mary K. Hayes, MD
    Former Medical Director and Chief of Women’s Imaging at Memorial Healthcare System and Envision

Note: This webinar is supported by Merit Medical through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 1/26/2021

Merit Medical

22nd Annual Meeting Symposium
The Preferred Localization Solution to Treat More Patients: SCOUT


Description:

SCOUT Radar localization exclusively spans the care continuum from time of biopsy placement to Targeted Axillary Dissection to excellent surgical outcomes. Discover the state-of-the art localization techniques practiced by key opinion leaders from the Cleveland Clinic, Columbia University, University of Colorado, Intermountain Healthcare and the Advocate System.


Note: Symposia at the Society's 22nd Annual Meeting were educational programs sponsored and funded by an outside organization, independently organized, and offered. This symposium was supported by Merit Medical through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 4/30/2021

Pacira BioSciences, Inc.

Optimizing Outpatient Breast Surgery: A Multidisciplinary Panel Discussion


Description:

The panel will evaluate critical factors in optimizing surgical results and recovery across in- and outpatient settings, including:

  • Patient selection and engagement
  • Communication, multimodal and culture change
  • Integrating experience and techniques from plastic surgery

Moderated by:

  • Shawna Willey, MD
    Peterson Chair of Breast Cancer Research
    Inova Schar Cancer Institute
    Inova Fairfax Hospital

Panelists:

  • Mark Brzezienski, MD
    University of Tennessee Health Science Center
    Professor of Plastic and Orthopedic Surgery
    Chairman and Program Director Department of Plastic Surgery
  • Jeff Gonzales, MD
    Staff Anesthesiologist
    Parker Adventist Hospital
  • Stephanie Valente, DO
    Breast Surgeon
    Cleveland Clinic

Questions:

For questions, please contact Erin.Fitzpatrick@pacira.com.


Note: This webinar is supported by Pacira BioSciences, Inc., through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 2/3/2021

Perimeter Medical Imaging AI, Inc.

Is OCT the Next Game Changer in Margin Visualization?


Description:

Join us as we present multiple patient cases using a new FDA-cleared intraoperative specimen imaging technology for real-time margin visualization of excised tissue and shaved margins with surgeons from three prestigious institutions involved in Perimeter’s clinical trials. This webinar provides a deeper dive on Optical Coherence Tomography (OCT) – an established, ultra high-resolution technology used in cardiology, dermatology and ophthalmology – and correlates OCT images to histopathology.

Brochure:

Access PDF

Speakers:

  • Nina Tamirisa, MD
    Assistant Professor, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
  • Maryam Elmi, MD
    Assistant Professor, Division of Surgical Oncology & Endocrine Surgery, University of Texas Health Science Center, San Antonio, TX
  • Stacey Carter, MD, FACS
    Assistant Professor of Surgery, Division of Surgical Oncology, Breast Surgery Section, Baylor College of Medicine, Houston, TX

Contact Information:

For more information, contact Andrew Berkeley at aberkeley@perimetermed.com or sales@perimetermed.com or call 214‑845‑5154.


Note: This webinar is supported by Perimeter Medical Imaging AI through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 10/5/2021

Perimeter Medical Imaging AI, Inc.

Next Generation in Surgical Specimen Imaging with Future AI Enhancements


Description:

Learn more about advancements in intraoperative specimen imaging. Optical Coherence Tomography (OCT), a high-resolution imaging modality commonly used in ophthalmology and cardiology, is ideally suited to visualizing margins during a surgical procedure. This webinar also includes insights into how Artificial Intelligence is moving towards the OR and Specimen Imaging.

Brochure:

Access PDF

Presentation Highlights

  • Intraoperative Specimen Imaging and the Role of OCT
  • OCT in the Operating Room and Case Reviews
  • Applying to AI to OCT Specimen Imaging

Speakers:

  • Hank Schmidt, MD, PhD
    Associate Professor of Surgery, Mount Sinai School of Medicine, Dubin Breast Center, Tisch Cancer Institute, New York, NY
  • Beth DuPree, MD, FACS, ABOIM
    Medical Director Oncology Service Line Centers of Northern Arizona at Northern Arizona Healthcare, AZ
  • Alastair Thompson, BSc (Hons), MBChB, MD, FRCS (Ed)
    Professor and Chief, Section of Breast Surgery, Division of Surgical Oncology, Bayor College of Medicine

Contact Information:

For more information, contact Andrew Berkeley at aberkeley@perimetermed.com.


Note: This webinar is planned and executed by Perimeter Medical Imaging AI, Inc. and promoted/shared by ASBrS through a paid marketing campaign. It is not part of the official education program of the ASBrS and will not meet any of the training criteria requirements of the ASBrS Oncoplastic Surgery Certification.
Originally Aired: 3/23/2021

Educational Grants & Marketing Support

Marketing support for the ASBrS 2021 Virtual Education Series is provided by Agendia, Ambry Genetics, Cardinal Health, Genentech, Hologic, Mammotome, Medtronic, Merit Medical, Pacira BioSciences, Inc., Perimeter Medical Imaging AI, Inc., and Stryker.

Marketing support for the ASBrS 2021 Annual Meeting is provided by 3M+KCI, Agendia, Endomag, Exact Sciences, Hologic, Mammotome, Medtronic, and Merit Medical.

 2020 Events on Demand

Agendia

Exact Sciences Corporation

Hologic

Mammotome

Medtronic

Myriad Genetics, Inc.

PeerView Institute


Agendia

From NBRST to MINDACT: The Clinical Utility of BluePrint and MammaPrint in the Pre- and Post-Operative Treatment Settings


Presenter:

  • Alberto Montero, MD; Director Breast Cancer Program, UH Seidman Cancer Center; Associate Professor, CWRU School of Medicine

Discussant:

  • James Pellicane, MD; Director of Breast Oncology, Bon Secours Cancer Institute

Description:

Please join our webinar for an interactive discussion of comprehensive genomic profiling and how it can facilitate patient-centered care. Dr. Montero will provide updates on the NBRST and MINDACT clinical trials and discuss the utility of MammaPrint and BluePrint in the pre- and post-operative treatment settings with Dr. Pellicane. We look forward to an impactful webinar and welcome audience participation during the Q&A session.

For More Information:

Contact Israel Madera, israel.madera@agendia.com.


Note: This webinar is supported by Agendia through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 10/19/2020

Exact Sciences (formerly Genomic Health, Inc.)

Less is More: De-escalation of Local and Systemic Therapy with the Breast Recurrence Score® Test


Presenters:

  • Julia White, MD, Ohio State University Comprehensive Cancer Center
  • Anthony Lucci, MD, University of Texas, MD Anderson Cancer Center
  • Moderated by Christy Russell, MD, Exact Sciences

Note: This satellite symposium is supported by Exact Sciences Corporation (formerly Genomic Health, Inc.) through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 5/28/2020

Hologic

Panel Discussion: Optimal Surgical Treatment of Breast Reconstruction & Localization with Cases


Description:

An interactive panel discussion designed to highlight optimal breast reconstruction, localization techniques, and radiation planning along with specimen radiography through examination of actual cases and outcomes. Participants will have an opportunity to ask questions, share perspectives and hear about the latest breast reconstruction methods from a multi-disciplinary team including surgery, radiology, and radiation oncology practicing in both academic and community-based centers.

Speakers:

  • Karen Barbosa, DO, FACOS
    Breast Surgeon
    University of Maryland Shore Regional Health, Clark Comprehensive Breast Center

  • Anthony Lucci, MD, FACS
    Department of Breast Surgical Oncology, Division of Surgery
    MD Anderson Cancer Center

  • Joshua Mondschein, MD, MSCI, DABR
    Radiation Oncologist
    Tennessee Oncology / Provisions Proton Therapy

For More Information:

Please contact MedEd-BSH@hologic.com.


Note: This symposium is supported by Hologic, Inc. through a marketing grant. It is not part of the official education program of the ASBrS.
Originally Aired: 6/22/2020

Mammotome

Changing the Standard of Care for Breast Surgery: Implementing Wire-Free Localization & Radiation-Free SLNB


Description:

Learn how Dr. McGuire is implementing wire-free localization and radiation-free SLNB technology that is changing her patient flow and improving outcomes. Advanced techniques such as delayed SLNB are now options for her patients.

1 Category A CEU, ASRT Approved

Presenter:

  • Kandace McGuire, MD, Virginia Commonwealth University

Note: This webinar is supported by Mammotome through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 5/13/2020

Mammotome

Leveraging Your Biopsy Markers (Part One): From Placement to Surgery


Description:

  • Review how the latest trends in NACT and Endocrine Therapy are changing patient flow
  • Learn how a marker can optimize patient care
  • Review case studies
  • Live Q&A

Note: This webinar is supported by Mammotome through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 11/4/2020

Mammotome

Leveraging Your Biopsy Markers (Part Two): Localization and Beyond


Description:

  • Advanced techniques of localizing with ultrasound
  • Review how the latest trends in NACT and Endocrine Therapy are changing patient flow
  • Review case studies
  • Live Q&A

Note: This webinar is supported by Mammotome through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 11/10/2020

Mammotome

Radiation-Free Targeted Axillary Dissection


Description:

Join Dr. Michael Alvarado as he discusses how to reduce your false negative rates with radiation-free targeted axillary dissection. Watch video demonstrations of Dr. Alvarado performing TAD and hear how using innovative localizing technology is improving outcomes for his patients.

Presenter:

  • Michael Alvarado, MD, University of San Francisco

Note: This webinar is supported by Mammotome through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 7/29/2020

Medtronic

Let’s Talk About: The Pandemic’s Impact on Breast Surgery IV


Description:

Join our faculty for a one-hour webinar as they discuss the pandemic’s impact on breast surgery. Jay Harness, MD will moderate a panel discussion with Shawna Willey, MD, Beth DuPree, MD, and William Scarlett, DO, as they exchange ideas and reflect on experiences around COVID-19 and the future of breast surgery. We encourage audience participation, discussion, and questions at the end. Please join us for an informative, interactive webinar.

Moderator:

  • Jay Harness, MD

Speakers:

  • Beth DuPree, MD
  • William Scarlett, DO
  • Shawna Willey, MD

For More Information:

Learn about PLASMABLADE™, Precise Soft Tissue Dissection Devices, or call 1‑866‑777‑9400.


Note: This webinar is supported by Medtronic through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 7/13/2020

Myriad Genetics, Inc.

Personalizing Breast Cancer Risks Beyond BRCA. riskScore®: Using the Next Generation of Risk Models for a More Precise and Personalized Cancer Risk


Description:

We will discuss how riskScore® is a precision medicine tool clinically validated to predict a woman’s risk of developing breast cancer. We will illustrate how it analyzes family history, personal clinical risk factors, and over 80 well-studied genetic markers to predict the risk of developing breast cancer over the next 5 years and remaining lifetime. In addition, we will cover possible advances such as expanding its availability to all ancestries and leveraging it to refine the risk for mutation carriers.

Brochure:

Access PDF

Program Objectives:

  1. Describe how riskScore® analyzes over 80 well-studied genetic markers and combined with the Tyrer-Cuzick model estimates a woman’s risk for developing breast cancer
  2. Learn how the model was validated and can be utilized in clinic today
  3. Summarize how the utilization of polygenic risk scores significantly modifies the risk of patients who carry a mutation

Speaker:

  • Thomas Slavin, MD, FACMG, DABCC
    SVP, Medical Affairs - Oncology | Myriad Genetics, Inc.

Note: This webinar is supported by Myriad Oncology through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 7/20/2020

PeerView Institute

The Era of Immuno-Oncology in TNBC: Navigating Evidence in Early-Stage & Advanced Disease, Practicalities of Integration, and Implications for Breast Surgeons


Description:

Immunotherapy has become a new pillar in the treatment arsenal for advanced triple-negative breast cancer (TNBC), and accumulating evidence is supporting its expansion into earlier disease stages as well. To make the most of this therapeutic approach as a component of multimodal management of patients, especially in curative intent settings, it is increasingly more important for breast surgeons, medical oncologists, radiation oncologists, pathologists, and other healthcare professionals to collaborate and coordinate the care of patients with TNBC.

This PeerView Live webcast provides up-to-date information and multidisciplinary perspectives on the current and emerging roles of immune checkpoint inhibitors and combinations throughout the disease continuum of TNBC, as well as practical guidance for optimal integration of these therapies into clinical practice, focusing on the most important implications for breast surgeons.

For More Information:

Contact PeerView at 1‑877‑833‑6141 or live@PeerView.com.


Note: This webinar is supported by Merck & Co., Inc., through an independent educational grant provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. CME credits for this program will be provided by Medical Learning Institute, Inc. It is not part of the official program of the ASBrS. This activity is free to all members.
Originally Aired: 8/13/2020

Educational Grants & Marketing Support
The ASBrS 2020 Virtual Education Series is supported through educational grants provided by 3M + KCI, Ambry Genetics, BD/Bard, Exact Sciences Corporation (formerly Genomic Health, Inc.), Genentech, Hologic, Inc., Invitae, John Wayne Cancer Foundation, Merck & Co., Inc., and TME and marketing support provided by Agendia, Ambry Genetics, Cardinal Health, Endomag, Exact Sciences Corporation (formerly Genomic Health, Inc.), Genentech, Hologic, Inc., Kubtec Medical Imaging, Mammotome, Medtronic, Myriad Genetics, Inc., PeerView Institute, and Stryker.